Synthesis and Cyclization of 8-Formyl-2-(phenoxymethyl)quinoline-3-carboxylic Acids
7.88—7.91 (m, 1H, ArH), 8.04 (d, J=8.4 Hz, 1H, ArH),
8.17 (d, J=8.4 Hz, 1H, ArH), 8.93 (s, 1H, CHO), 13.47
(s, 1H, COOH); 13C NMR (DMSO-d6, 150 MHz) δ:
70.82, 116.59, 124.50, 124.74, 126.44, 127.78, 128.65,
129.00, 129.25, 132.01, 139.79, 147.35, 154.94, 157.61,
167.36; IR (KBr) ν: 3446 (OH), 1761 (C=O), 1697
(C=O) cm ; ESI-MS m/z: 341.1 (M ). Anal. calcd for
C18H12ClNO4: C 63.26, H 3.54, N 4.10; found C 63.37,
H 3.41, N 4.06.
13C NMR (DMSO-d6, 150 MHz) δ: 76.25, 120.94,
122.93, 125.34, 127.13, 127.88, 128.66, 129.69, 131.59,
132.29, 132.53, 136.12, 139.65, 148.35, 154.59, 160.96,
-
1
187.73; IR (KBr) ν: 1701 (C=O), 1641 (C=O) cm ;
ESI-MS m/z: 289.3 (M+). Anal. calcd for C18H11NO3: C
74.73, H 3.83, N 4.84; found C 74.84, H 3.71, N 4.80.
-
+
1
2-Methyl-13-oxo-6,13-dihydro[1]benzoxepino[3,4-b]-
quinoline-8-carbaldehyde (5b)
1H NMR (DMSO-d6, 600 MHz) δ: 2.36 (s, 3H, CH3),
5.51 (s, 2H, OCH2-Ar), 7.11 (d, J=8.4 Hz, 1H, ArH),
7.47 (dd, J=8.4, 1.8 Hz, 1H, ArH), 7.74 (t, J=7.2 Hz,
1H, ArH), 7.93—7.96 (m, 1H, ArH), 7.99 (d, J=1.2 Hz,
1H, ArH), 8.13 (d, J=8.4 Hz, 1H, ArH), 8.24 (d, J=7.8,
1H, ArH), 8.94 (s, 1H, CHO); 13C NMR (DMSO-d6,
150 MHz) δ: 20.1, 76.33, 120.87, 125.03, 127.15,
127.87, 128.65, 129.68, 131.10, 131.99, 132.26, 137.00,
139.70, 148.33, 154.80, 159.11, 187.69; IR (KBr) ν:
2-((4-Bromophenoxy)methyl)-8-formylquinoline-3-
carboxylic acid (4g)
1H NMR (DMSO-d6, 600 MHz) δ: 5.60 (s, 2H,
OCH2-Ar), 6.97—6.99 (m, 2H, ArH), 7.43—7.46 (m,
2H, ArH), 7.69—7.73 (m, 1H, ArH), 7.88—7.91 (m, 1H,
ArH), 8.04 (d, J=8.4 Hz, 1H, ArH), 8.17 (d, J=7.8 Hz,
1H, ArH), 8.93 (s, 1H, CHO), 13.46 (s, 1H, COOH);
13C NMR (DMSO-d6, 150 MHz) δ: 70.74, 112.21,
117.13, 124.74, 126.44, 127.79, 128.65, 129.01, 132.02,
132.14, 139.79, 147.34, 154.92, 158.06, 167.35; IR
-
1
1689 (C=O), 1629 (C=O) cm ; ESI-MS m/z: 303.3
(M+). Anal. calcd for C19H13NO3: C 75.24, H 4.32, N
4.62; found C 75.36, H 4.29, N 4.58.
-
1
(KBr) ν: 3428 (OH), 1780 (C=O), 1695 (C=O) cm ;
ESI-MS m/z: 384.9 (M+). Anal. calcd for C18H12BrNO4:
C 55.98, H 3.13, N 3.63; found C 55.86, H 3.26, N 3.59.
3-Methyl-13-oxo-6,13-dihydro[1]benzoxepino[3,4-b]-
quinoline-8-carbaldehyde (5c)
1H NMR (CDCl3, 600 MHz) δ: 2.39 (s, 3H, CH3),
5.48 (s, 2H, OCH2-Ar), 6.96 (s, 1H, ArH), 7.01 (d, J=
8.4 Hz, 1H, ArH), 7.63 (t, J=7.2 Hz ,1H, ArH ), 7.84 (t,
J=7.8 Hz, 1H, ArH ), 7.98 (d, J=7.8 Hz, 1H, ArH),
8.14 (d, J=8.4 Hz, 1H, ArH), 8.22 (d, J=8.4 Hz, 1H,
ArH), 8.83 (s, 1H, CHO); 13C NMR (CDCl3, 150 MHz)
δ: 21.51, 120.98, 123.36, 124.17, 127.59, 129.15,
129.19, 132.01, 132.07, 132.69, 139.85, 147.37, 148.96,
154.59, 161.53, 187.98; IR (KBr) ν: 1709 (C=O), 1629
8-Formyl-2-((2-nitrophenoxy)methyl)quinoline-3-
carboxylic acid (4h)
1H NMR (DMSO-d6, 600 MHz) δ: 5.83 (s, 2H,
OCH2-Ar), 7.10—7.13 (m, 1H, ArH), 7.48 (d, J=8.4
Hz, 1H, ArH), 7.60—7.63 (m, 1H, ArH), 7.70—7.73 (m,
1H, ArH), 7.87—7.91 (m, 2H, ArH), 7.99 (d, J=8.4 Hz,
1H, ArH), 8.18 (d, J=7.8 Hz, 1H, ArH), 8.98 (s, 1H,
CHO), 13.45 (s, 1H, COOH); 13C NMR (DMSO-d6, 150
MHz) δ: 71.74, 115.81, 120.78, 124.13, 124.94, 126.47,
127.86, 128.61, 129.10, 132.16, 134.34, 139.85, 140.34,
147.34, 151.71, 154.43, 166.90; IR (KBr) ν: 3438 (OH),
-
+
1
(C=O) cm ; ESI-MS m/z: 303.3 (M ). Anal. calcd for
C19H13NO3: C 75.24, H 4.32, N 4.62; found C 75.18, H
4.40, N 4.57.
-
1
1711 (C=O), 1630 (C=O) cm ; ESI-MS m/z: 351.9
(M+). Anal. calcd for C18H12N2O6: C 61.37, H 3.43, N
7.95; found C 61.15, H 3.53, N 7.82.
4-Methyl-13-oxo-6,13-dihydro[1]benzoxepino[3,4-b]-
quinoline-8-carbaldehyde (5d)
1H NMR (CDCl3, 600 MHz) δ: 2.33 (s, 3H, CH3),
5.52 (s, 2H, OCH2-Ar), 7.08 (t, J=7.8 Hz, 1H, ArH),
7.42 (d, J=7.2 Hz, 1H, ArH), 7.62 (t, J=7.8 Hz, 1H,
ArH), 7.84 (t, J=7.8 Hz, 1H, ArH), 7.97 (d, J=7.8 Hz,
1H, ArH), 8.14 (dd, J=8.4, 4.2 Hz, 2H, ArH), 8.81 (s,
1H, CHO); 13C NMR (CDCl3, 150 MHz) δ: 16.54,
122.25, 125.79, 127.58, 129.14, 129.19, 129.78, 129.93,
132.01, 132.69, 136.72, 139.69, 148.99, 154.73, 159.79,
General procedure for the preparation of 13-oxo-
6,13–dihydro[1]benzoxepino[3,4-b]quinoline-8-carb-
aldehyde derivatives (5a—5g)
Quinolinic acids 4a—4g (1 mmol) and 12 g PPA
were added to 25 mL round flask and stirred at 125 ℃
for 3 h. Then the reaction mixture was poured slowly
with stirring into an icy saturated sodium carbonate so-
lution. The crude product was obtained after filtration
and washed with water. The pure products 5a—5g were
obtained by recrystalization from 95% ethanol. Yields
and melting points are indicated in Table 2.
-
1
188.98; IR (KBr) ν: 1716 (C=O), 1643(C=O) cm ;
ESI-MS m/z: 303.3 (M+). Anal. calcd for C19H13NO3: C
75.24, H 4.32, N 4.62; found C 75.28, H 4.27, N 4.55.
13-Oxo-6,13–dihydro[1]benzoxepino[3,4-b]quinoline-
8-carbaldehyde (5a)
3-Methoxy-13-oxo-6,13-dihydro[1]benzoxepino[3,4-
b]quinoline-8-carbaldehyde (5e)
1H NMR (DMSO-d6, 600 MHz) δ: 5.56 (s, 2H,
OCH2-Ar), 7.22 (d, J=8.4 Hz, 1H, ArH), 7.28 (t, J=
7.8 Hz, 1H, ArH), 7.65—7.68 (m, 1H, ArH ), 7.74 (t,
J=7.2, 1H, ArH), 7.94—7.96 (m, 1H, ArH), 8.14 (d,
J=8.4 Hz, 1H, ArH), 8.21 (dd, J=8.4, 1.8 Hz, 1H,
ArH), 8.24 (d, J=7.8 Hz, 1H, ArH), 8.95 (s, 1H, CHO);
1H NMR (DMSO-d6, 600 MHz) δ: 3.84 (s, 3H,
OCH3); 5.51 (s, 2H, OCH2-Ar), 6.70 (d, J=9.0 Hz, 1H,
ArH), 6.85 (dd, J=9.0, 2.4 Hz, 1H, ArH), 7.70—7.73
(m, 1H, ArH), 7.91—7.94 (m, 1H, ArH), 8.11 (d, J=8.4
Hz, 1H, ArH), 8.16 (d, J=9.0 Hz, 1H, ArH), 8.22 (d,
J=7.8 Hz, 1H, ArH), 8.92 (s, 1H, CHO); 13C NMR
Chin. J. Chem. 2012, 30, 1127—1132
© 2012 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1129